| The determinants of national innovative capacity JL Furman, ME Porter, S Stern Research policy 31 (6), 899-933, 2002 | 4248 | 2002 |
| Catching up or standing still?: National innovative productivity among ‘follower’countries, 1978–1999 JL Furman, R Hayes Research policy 33 (9), 1329-1354, 2004 | 500 | 2004 |
| Climbing atop the shoulders of giants: The impact of institutions on cumulative research JL Furman, S Stern American Economic Review 101 (5), 1933-1963, 2011 | 481 | 2011 |
| Governing knowledge in the scientific community: Exploring the role of retractions in biomedicine JL Furman, K Jensen, F Murray Research Policy 41 (2), 276-290, 2012 | 202 | 2012 |
| Firm performance and state innovation funding: Evidence from China’s Innofund program Y Wang, J Li, JL Furman Research Policy 46 (6), 1142-1161, 2017 | 174 | 2017 |
| Public & private spillovers, location and the productivity of pharmaceutical research JL Furman, M Kyle, IM Cockburn, R Henderson National Bureau of Economic Research, 2006 | 174 | 2006 |
| Academic science and the birth of industrial research laboratories in the US pharmaceutical industry JL Furman, MJ MacGarvie Journal of Economic Behavior & Organization 63 (4), 756-776, 2007 | 165* | 2007 |
| An NCI perspective on creating sustainable biospecimen resources J Vaught, J Rogers, K Myers, MD Lim, N Lockhart, H Moore, S Sawyer, ... Journal of the national cancer institute monographs 2011 (42), 1-7, 2011 | 138 | 2011 |
| Retractions P Azoulay, JL Furman, F Murray, JL Krieger Review of Economics and Statistics 97 (5), 1118-1136, 2015 | 133 | 2015 |
| Disclosure and subsequent innovation: Evidence from the patent depository library program JL Furman, M Nagler, M Watzinger American Economic Journal: Economic Policy 13 (4), 239-270, 2021 | 84 | 2021 |
| Automation, research technology, and researchers’ trajectories: Evidence from computer science and electrical engineering JL Furman, F Teodoridis Organization Science 31 (2), 330-354, 2020 | 78* | 2020 |
| Academic collaboration and organizational innovation: the development of research capabilities in the US pharmaceutical industry, 1927–1946 JL Furman, M MacGarvie Industrial and Corporate Change 18 (5), 929-961, 2009 | 75 | 2009 |
| Safeguarding the bioeconomy National Academies of Sciences, Division on Engineering, ... National Academies Press, 2020 | 74 | 2020 |
| Growing stem cells: The impact of federal funding policy on the US scientific frontier JL Furman, F Murray, S Stern Journal of Policy Analysis and Management 31 (3), 661-705, 2012 | 73* | 2012 |
| Location and organizing strategy: Exploring the influence of location on the organization of pharmaceutical research JL Furman Geography and strategy 20, 49-87, 2003 | 50 | 2003 |
| Turnarounds JL Furman, AM McGahan Managerial and Decision Economics 23 (4‐5), 283-300, 2002 | 40 | 2002 |
| Understanding the Drivers of National Innovative Capacity. JL Furman, ME Porter, S Stern Academy of management proceedings 2000 (1), A1-A6, 2000 | 39 | 2000 |
| Essays on the role of location in strategy JL Furman Massachusetts Institute of Technology, 2001 | 37* | 2001 |
| Los factores impulsores de la capacidad innovadora nacional: implicaciones para España y América Latina ME Porter, JL Furman, S Stern Claves de la economía mundial 1, 78-88, 2000 | 30* | 2000 |
| More for the research dollar JL Furman, F Murray, S Stern Nature 468 (7325), 757-758, 2010 | 15 | 2010 |
Scott SternDavid Sarnoff Professor of Management, MIT在 mit.edu 的电子邮件经过验证
